164 related articles for article (PubMed ID: 26338254)
21. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
22. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
23. Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.
Zhang M; Ren B; Li Z; Niu W; Wang Y
Med Sci Monit; 2017 Sep; 23():4644-4649. PubMed ID: 28953854
[TBL] [Abstract][Full Text] [Related]
24. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
[TBL] [Abstract][Full Text] [Related]
25. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
[TBL] [Abstract][Full Text] [Related]
26. Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer.
Mutlu N; Turkeri L; Emerk K
Clin Chem Lab Med; 2003 Aug; 41(8):1069-74. PubMed ID: 12964816
[TBL] [Abstract][Full Text] [Related]
27. Urinary Cell-Free DNA in Bladder Cancer Detection.
Tse RT; Zhao H; Wong CY; Cheng CK; Kong AW; Peng Q; Chiu PK; Ng CF; Teoh JY
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672869
[TBL] [Abstract][Full Text] [Related]
28. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
Chen YT; Chen HW; Domanski D; Smith DS; Liang KH; Wu CC; Chen CL; Chung T; Chen MC; Chang YS; Parker CE; Borchers CH; Yu JS
J Proteomics; 2012 Jun; 75(12):3529-45. PubMed ID: 22236518
[TBL] [Abstract][Full Text] [Related]
29. Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.
Khadjavi A; Mannu F; Destefanis P; Sacerdote C; Battaglia A; Allasia M; Fontana D; Frea B; Polidoro S; Fiorito G; Matullo G; Pantaleo A; Notarpietro A; Prato M; Castagno F; Vineis P; Gontero P; Giribaldi G; Turrini F
Br J Cancer; 2015 Jul; 113(3):469-75. PubMed ID: 26125446
[TBL] [Abstract][Full Text] [Related]
30. Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer.
Andersson E; Dahmcke CM; Steven K; Larsen LK; Guldberg P
PLoS One; 2015; 10(7):e0131889. PubMed ID: 26151138
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis.
Eissa S; Habib H; Ali E; Kotb Y
Med Oncol; 2015 Jan; 32(1):413. PubMed ID: 25511320
[TBL] [Abstract][Full Text] [Related]
32. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
33. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
[TBL] [Abstract][Full Text] [Related]
37. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
[TBL] [Abstract][Full Text] [Related]
38. Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
Chen M; Chan RWY; Cheung PPH; Ni M; Wong DKL; Zhou Z; Ma ML; Huang L; Xu X; Lee WS; Wang G; Lui KO; Lam WKJ; Teoh JYC; Ng CF; Jiang P; Chan KCA; Chiu RWK; Lo YMD
PLoS Genet; 2022 Jul; 18(7):e1010262. PubMed ID: 35793278
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of bladder cancer using telomerase activity in voided urine.
Cheng CW; Chueh SC; Chern HD
J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
[TBL] [Abstract][Full Text] [Related]
40. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]